Abstract:BCL11B is a transcription factor with six C 2 H 2 -type zinc-finger domains. Studies in mice have shown that Bcl11b plays essential roles in T cell development. Several germline heterozygous BCL11B variants have been identified in human patients with inborn errors of immunity (IEI) patients. Among these, two de novo mis-sense variants cause asparagine (N) to lysine (K) replacement in distinct zinc-finger domains, BCL11B N441K and BCL11B N807K . To elucidate the pathogenesis of the BCL11B N807K variant, we generated a mouse model of BCL11B N807K by inserting the corresponding mutation, Bcl11b N797K , into the mouse genome. In Bcl11b +/N797K mice, the proportion of immature CD4 − CD8 + single-positive thymocytes was increased, and the development of invariant natural killer cells was severely inhibited in a T-cell-intrinsic manner. Under competitive conditions, γδT cell development was outcompeted by control cells. Bcl11b N797K/N797K mice died within one day of birth. Recipient mice reconstituted with Bcl11b N797K/N797K fetal liver cells nearly lacked CD4 + CD8 + double-positive thymocytes, which was consistent with the lack of their emergence in culture from Bcl11b N797K/N797K fetal liver progenitors. Interestingly, Bcl11b N797K/N797K progenitors gave rise to aberrant c-Kit + and CD44 + cells both in vivo and in vitro . The increase in the proportion of immature CD8 single-positive thymocytes in the Bcl11b N797K mutants is caused, in part, by the inefficient activation of the Cd4 gene due to the attenuated function of the two Cd4 enhancers via distinct mechanisms. Therefore, we conclude that immunodeficient patient-derived Bcl11b N797K mutant mice elucidated a novel role for Bcl11b in driving the appropriate transition of CD4 − CD8 − into CD4 + CD8 + thymocytes.

Bcl11b-A Critical Neurodevelopmental Transcription Factor-Roles in Health and Disease.

BCL11b interacts with RNA and proteins involved in RNA processing and developmental diseases

Bcl11b: a novel regulator of T-lineage commitment

Critical roles of Bcl11b in T‐cell development and maintenance of T‐cell identity

Bcl11b is a Positive Regulator of T-lineage Specification (85.19)

Pivotal role of BCL11B in the immune, hematopoietic and nervous systems: a review of the BCL11B-associated phenotypes from the genetic perspective

The Role of Bcl11 Transcription Factors in Neurodevelopmental Disorders

Function of B-Cell CLL/Lymphoma 11B in Glial Progenitor Proliferation and Oligodendrocyte Maturation

A mutant BCL11B-N440K protein interferes with BCL11A function during T lymphocyte and neuronal development

The Role of BCL11B in Regulating the Proliferation of Human Naive T Cells.

Bcl11a is Essential for Lymphoid Development and Negatively Regulates P53

Bcl11b and combinatorial resolution of cell fate in the T-cell gene regulatory network

A Conserved Regulator of Immunity and Beyond

The role of B-cell lymphoma/leukemia 11A (BCL11A) in the malignant progression of solid tumors

The transcription factor Bcl11b is specifically expressed in group 2 innate lymphoid cells and is essential for their development.

Molecular Analysis Of T-Lineage Commitment: A Possible Role For Bcl11b

The Role of BCL11B in Hematological Malignancy

The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation

Dual role of BCL11B in T-cell malignancies

B-cell lymphoma/leukaemia 11B (BCL11B) expression status helps distinguish early T-cell precursor acute lymphoblastic leukaemia/lymphoma (ETP-ALL/LBL) from other subtypes of T-cell ALL/LBL

A Bcl11bN797K variant isolated from an immunodeficient patient inhibits early thymocyte development in mice